Five leading universities, including the University of Cambridge, have formed a partnership to develop and commercialise agritech research, in order to improve sustainability, increase productivity and contribute to global food security.
Researchers from the UK and Denmark have developed a new method to predict the physical stability of drug candidates, which could help with the development of new and more effective medicines for patients. The technology has been licensed to Cambridge spin-out company TeraView, who are developing it for use in the pharmaceutical industry in order to make medicines that are more easily released in the body.
Today we begin a month-long focus on research related to artificial intelligence. Here, four researchers reflect on the power of a technology to impact nearly every aspect of modern life – and why we need to be ready.
Andy Neely is Cambridge’s Pro-Vice-Chancellor for Enterprise and Business Relations, a role which oversees the University’s activities in innovation, commercialisation and entrepreneurship. After six months in the role, he sees an entrepreneurial ecosystem that may appear complex at first – but a deeper examination reveals a combination of knowledge, expertise, support and infrastructure that makes Cambridge one of the most enterprising and entrepreneurial cities in the world.
When it comes to starting social enterprises, Paul Tracey and Neil Stott would love "to see a thousand flowers bloom". But doing good for society isn’t as straightforward as it sounds and even the best ideas can fail. Their research aims to understand the elements that are needed to help social ventures thrive.
A microscopic ‘pen’ that is able to write structures small enough to trap and harness light using a commercially available printing technique could be used for sensing, biotechnology, lasers, and studying the interaction between light and matter.
Dr Tim Minshall has been appointed as the inaugural Dr John C Taylor Professor of Innovation at the University of Cambridge, a new post that will build on the University’s strengths in science, engineering and entrepreneurship. Dr Minshall, who is currently Reader in Technology & Innovation Management in the Department of Engineering and Fellow of Churchill College, will take up his new post on 1 October.
In this piece for The Conversation, Carlos López-Gómez from Cambridge's Institute for Manufacturing, discusses the role that small and medium-sized businesses might play in a post-Brexit economy.
Cambridge-based start-up company Bicycle Therapeutics has recently raised £40 million from a range of investors to bring its cancer drug candidates to clinical trials.
A University of Cambridge spin-out company has raised £7 million in new funding, which will help in the development of treatments for liver and lung disease.